EUVIMEDEUVIMED entdecken
Crossref

Osteoarthritis as an aging-driven multi-tissue disorder - genomic instability, cellular senescence, and emerging gerotherapeutic strategies

Khaled A Abdel-Sater

Clinical review for general practice · 16.11.2026 · 7 (9) · 91-93

DOI: 10.47407/kr2026.7.9.00935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical review for general practice, online erschienen am 16.11.2026. Verfasst von Khaled A Abdel-Sater.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Osteoarthritis (OA) is the most common musculoskeletal disorder and a major cause of disability in older adults. Once considered primarily a consequence of mechanical wear, OA is now recognized as an aging-driven, multi-tissue degenerative disease. Processes such as genomic instability, mitochondrial dysfunction, and cellular senescence play central roles in disease initiation and progression. Objective and methods. This review synthesizes mechanistic evidence linking biological aging to OA pathogenesis and evaluates emerging senescence-targeted therapies. A PRISMA-informed narrative search of PubMed, Embase, Cochrane Central, and Google Scholar identified 86 relevant clinical and preclinical studies from 360 screened records.

Results

Aging chondrocytes accumulate DNA damage, telomere shortening, and metabolic dysfunction, leading to persistent senescence and a pro-inflammatory SASP. Senescent cells across cartilage, synovium, subchondral bone, and adipose tissue interact via paracrine and extracellular vesicle signaling, driving chronic inflammation and matrix degradation. Preclinical data show that interventions targeting aging hallmarks – including senolytics, senomorphics, autophagy activation, NAD⁺ restoration, stem cell-based therapies, and lifestyle modification–can reduce senescence burden and slow structural decline, though human evidence remains limited.

Conclusion

OA should be reframed as an aging-mediated systemic joint disorder rather than isolated cartilage failure. Therapies addressing upstream mechanisms of cellular aging offer realistic potential for disease modification, but successful translation will require age-adapted clinical strategies and biomarker-guided patient selection. Keywords: osteoarthritis, aging, genomic instability, chondrocyte senescence, SASP.

Zitieren

APA

Abdel-Sater, K. A. (2026). Osteoarthritis as an aging-driven multi-tissue disorder - genomic instability, cellular senescence, and emerging gerotherapeutic strategies. Clinical review for general practice, 7(9), 91-93. https://doi.org/10.47407/kr2026.7.9.00935

Vancouver

Abdel-Sater KA. Osteoarthritis as an aging-driven multi-tissue disorder - genomic instability, cellular senescence, and emerging gerotherapeutic strategies. Clinical review for general practice. 2026;7(9):91-93. doi:10.47407/kr2026.7.9.00935

BibTeX
@article{AbdelSater2026,
  author = {Abdel-Sater, Khaled A},
  title = {Osteoarthritis as an aging-driven multi-tissue disorder - genomic instability, cellular senescence, and emerging gerotherapeutic strategies},
  journal = {Clinical review for general practice},
  year = {2026},
  volume = {7},
  number = {9},
  pages = {91--93},
  doi = {10.47407/kr2026.7.9.00935}
}
Kostenlos starten →